Methods and apparatus for delivering a drug influencing appetite for treatment of eating disorders
AssigneeMedtronic, Inc.
InventorWarren L. Starkebaum
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedtronic, Inc.
InventorWarren L. Starkebaum
Estimating the term…
Methods and systems for treating patients suffering from eating disorders, e.g. obesity, through the dispensation of a drug by an implantable infusion pump (IIP) delivering drug into the cerebral spinal fluid (CSF) at a site of the intrathecal space in amounts and at times effective to suppress the patient's appetite through interaction of the drug transported through the CSF with receptors in the brain. Delivery of a programmed drug dosage is preferably by one of time-out of programmed time(s) of day, a command received from the patient, or a trigger signal developed from a sensed GI tract signal accompanying peristalsis.
A method of delivering drug from an implantable infusion pump to receptors of the brain to therapeutically treat an eating disorder of a patient by suppressing or enhancing appetite, the method comprising the steps of:
A method of delivering drug from an implantable infusion pump to receptors of the brain to therapeutically treat an eating disorder of a patient by suppressing or enhancing appetite, the method comprising the steps of:
A system comprising an implantable infusion pump for delivering drug to receptors of the brain to therapeutically treat an eating disorder of a patient by suppressing or enhancing the patient's appetite, the system comprising:
A system delivering drug from an implantable infusion pump to receptors of the brain to therapeutically treat an eating disorder of a patient by suppressing or enhancing appetite comprising:
Dependencies are inferred from the claim text.